Rationale: Several mutations that impair the development of blood lineages in the mouse also impair the formation of the lymphatic vasculature and its separation from the blood vasculature. However, the basis for these defects has remained unknown because the mutations characterized affect more than one blood lineage. Objective: We tested the hypothesis that megakaryocytes/platelets are required for the formation of the lymphatic vasculature and its separation from the blood vascular system. Methods and Results: We characterized the vascular patterning defects of mice deficient for the homeodomain transcription factor Meis1 (myeloid ecotropic viral integration site 1), which completely lack megakaryocyte/ platelets. 10.5. 2 This activates expression of lymphaticspecific molecules and the formation of lymphatic sacs from the vein-derived lymphendothelial precursors, stimulated by vascular endothelial growth factor-C/vascular endothelial growth factor receptor 3. 3,4 The mature postnatal lymphatic vasculature is completely independent of the blood vascular system, except for the connections of the thoracic and right ducts with the subclavian veins, through which lymph drains into the blood circulation. At these junctions, specialized valves prevent blood reflux into the lymphatic vessels. 5 However, during development, connections between the venous system and the forming lymphatic vasculature lack valves and therefore additional mechanisms must ensure their separation. Mutations in Syk and Slp-76 6,7 and Runx1, 1 all affecting the development of blood lineages, block separation of the blood and lymphatic vasculature; however, the nature of the cell lineages involved and the mechanisms by which they control blood/lymphatic vessel separation remains unclear, because all mutations studied affect more than one blood lineage. Meis1 (myeloid ecotropic viral integration site 1) encodes a homeodomain transcription factor important for definitive hematopoietic stem cell development in the
MethodsImmunohistochemistry and immunofluorescence were performed as previously described. 8 Primary antibodies were as follows: anti-CD31 (553370) and anti-CD41 (553847) (BD BiosciencesPharmingen); anti-CD61 (NB100 -79980CC, Novus Biologicals); anti-Lyve-1 (103-PA50S ReliaTech); and anti-Meis1. 8 Secondary antibodies were as follows: biotinylated goat antirat (Ab7096, Abcam) and goat anti-rabbit biotin (111-066-003, Jackson Immunoresearch), followed by Streptavidin-Alexa 488 (s-11223, Invitrogen) or -Cy3 (016-160-084, Jackson Immunoresearch). For immunohistochemistry, we used Vectastain ABC (Vector Laboratories) with alkaline phosphatase (AK-5000) and developed with FastRed (11496549001, Roche Diagnostic). Whole mount in situ hybridization was performed using standard procedures. Riboprobes were obtained by SP6 polymerase transcription from cDNA PCR-amplified fragments.Meis1 mutant mice 8 were backcrossed to C57BL/6J mice for more than 20 generations. Platelet factor (PF)4-Cre 9 and R26:lacZbpAfloxDTA 10 were backcrossed to the C57...